在药物系统综述中检索临床试验注册库的影响:方法学系统综述与Meta分析再分析
该研究评估在药物系统综述中检索临床试验注册库的影响。通过方法学系统综述和Meta分析再分析发现,在95篇系统综述中检索注册库后,41篇(43%)额外识别出122项随机对照试验(RCT),部分系统综述患者数增加超过10%至50%,但额外RCT带来的汇总效应变化均未导致结果解读发生定性改变。
要点
- 在95篇系统综述中检索注册库后,41篇(43%)额外识别出122项RCT,54篇(57%)未发现额外RCT。
- 检索使19篇系统综述患者数增加超过10%,10篇超过20%,7篇超过30%,4篇超过50%。
- 14篇系统综述被再分析,额外RCT权重范围为0%至58%,汇总统计量变化范围为0%至29%,但均未导致结果解读发生定性改变。
核心结论
- 临床试验注册库是识别额外RCT的重要来源,检索后纳入的额外RCT和患者数量因系统综述而异,但额外试验带来的汇总效应变化均未导致结果解读发生定性改变。
研究设计与样本
- 方法学系统综述与Meta分析再分析,检索Medline识别2014年6月至2015年1月发表的药物RCT系统综述。
- 对未报告注册库检索但报告了检索所需信息的系统综述,检索WHO国际临床试验注册平台(WHO ICTRP)查找未纳入的已完成或终止RCT。
- 由两名研究者独立提取结局、患者数和治疗效果,并判断额外RCT结果是否可得,必要时再分析Meta分析。
主要发现
- 共纳入223篇系统综述,116篇(52%)未报告检索试验注册库,其中21篇未报告检索所需信息(关键词、检索日期)。
- 对95篇系统综述进行检索,54篇(57%)未发现额外RCT,41篇(43%)识别出122项额外RCT。
- 检索使19篇系统综述患者数增加超过10%,10篇超过20%,7篇超过30%,4篇超过50%。
- 63项RCT有结果可得,其中45项可纳入Meta分析;14篇系统综述被再分析,额外RCT权重范围为0%至58%,在5/14篇中大于10%,3篇中大于20%,1篇中大于50%。
- 汇总统计量变化范围为0%至29%,在5/14篇中大于10%,2篇中大于20%;但均未导致结果解读发生定性改变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective To evaluate the impact of searching clinical trial registries in systematic reviews.Design Methodological systematic review and reanalyses of meta-analyses.Data sources Medline was searched to identify systematic reviews of randomised controlled trials (RCTs) assessing pharmaceutical treatments published between June 2014 and January 2015. For all systematic reviews that did not report a trial registry search but reported the information to perform it, the World Health Organization International Trials Registry Platform (WHO ICTRP search portal) was searched for completed or terminated RCTs not originally included in the systematic review.Data extraction For each systematic review, two researchers independently extracted the outcomes analysed, the number of patients included, and the treatment effect estimated. For each RCT identified, two researchers independently determined whether the results were available (ie, posted, published, or available on the sponsor website) and extracted the data. When additional data were retrieved, we reanalysed meta-analyses and calculated the weight of the additional RCTs and the change in summary statistics by comparison with the original meta-analysis.Results Among 223 selected systematic reviews, 116 (52%) did not report a search of trial registries; 21 of these did not report the information to perform the search (key words, search date). A search was performed for 95 systematic reviews; for 54 (57%), no additional RCTs were found and for 41 (43%) 122 additional RCTs were identified. The search allowed for increasing the number of patients by more than 10% in 19 systematic reviews, 20% in 10, 30% in seven, and 50% in four. Moreover, 63 RCTs had results available; the results for 45 could be included in a meta-analysis. 14 systematic reviews including 45 RCTs were reanalysed. The weight of the additional RCTs in the recalculated meta-analyses ranged from 0% to 58% and was greater than 10% in five of 14 systematic reviews, 20% in three, and 50% in one. The change in summary statistics ranged from 0% to 29% and was greater than 10% for five of 14 systematic reviews and greater than 20% for two. However, none of the changes to summary effect estimates led to a qualitative change in the interpretation of the results once the new trials were added.Conclusions Trial registries are an important source for identifying additional RCTs. The additional number of RCTs and patients included if a search were performed varied across systematic reviews.
引用
- Baudard M, Yavchitz A, Ravaud P, et al. Impact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analyses. BMJ. 2017. PMID: 28213479. doi:10.1136/bmj.j448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。